R
Raktim K. Ghosh
Researcher at Case Western Reserve University
Publications - 56
Citations - 1021
Raktim K. Ghosh is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Heart failure & Atrial fibrillation. The author has an hindex of 13, co-authored 54 publications receiving 732 citations. Previous affiliations of Raktim K. Ghosh include Maulana Azad Medical College & Royal Stoke University Hospital.
Papers
More filters
Journal ArticleDOI
Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week
Somedeb Ball,Raktim K. Ghosh,Sariya Wongsaengsak,Dhrubajyoti Bandyopadhyay,Gopal Chandra Ghosh,Wilbert S. Aronow,Gregg C. Fonarow,Daniel J. Lenihan,Deepak L. Bhatt,Deepak L. Bhatt +9 more
TL;DR: This review summarizes the most updated evidence on epidemiology, pathophysiological mechanisms, and management strategies of various CVAEs associated with ICIs and highlights from recent guidelines published by National Comprehensive Cancer Network on ICI-related CV toxicities.
Journal ArticleDOI
SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus.
TL;DR: Results of ongoing phase III clinical trials are crucial to determine whether the risk‐benefit ratio will allow approval of this new class of drugs for the management of type 2 diabetes mellitus.
Journal ArticleDOI
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
TL;DR: A review article summarizes pharmacological characteristics of these novel antidotes, coagulation's tests affected, available clinical and preclinical data, and the need for phase III and IV studies.
Journal ArticleDOI
Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India
TL;DR: There is a lack of communication between doctors and patients regarding CAM, which may be improved by sensitization of doctors and inclusion of CAM in the medical curriculum.
Journal ArticleDOI
Recent advances in antiretroviral drugs.
TL;DR: The initial clinical trial data of these newer drugs are very encouraging for the long-term successful control of HIV in both treatment-naïve and treatment-experienced patients.